Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-18 Sale |
2024-12-19 6:57 pm |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
18,709 | $41.21 | $770,912 | 6,000 (Direct) |
View |
| 2022-09-02 Sale |
2022-09-07 4:26 pm |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
15,355 | $39.57 | $607,597 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-18 Exercise |
2024-12-19 6:57 pm |
N/A 2029-09-15 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
25,334 | $0 | 6,000 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-19 6:57 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
16,000 | $11.58 | 6,000 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-19 6:57 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
9,334 | $9.44 | 6,000 (Direct) |
View |
| 2024-12-18 Tax Withholding |
2024-12-19 6:57 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
6,625 | $41.28 | 6,000 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:41 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 4:25 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A 2029-09-15 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
18,648 | $0 | 0 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
813 | $8.4 | 0 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
32 | $7.49 | 0 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
9,000 | $9.44 | 0 (Direct) |
View |
| 2022-09-02 Tax Withholding |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
3,293 | $39.53 | 0 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
2,292 | $3.1 | 0 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
6,511 | $4.75 | 0 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:11 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 4:42 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2021-06-03 4:35 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
0 | $0 | 71,982 (Direct) |
View |